pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Ophthalmology · news · pharmadog
← back to Ophthalmology
News · Ophthalmology
406
stories
15d
Opinion: How meditation helped me become a better doctor overnight
stat
16d
Washington state resident dies from bird flu following exposure to infected cattle
stat
16d
Sun Pharma stops eye-care drug production at Indian plant amid quality issues
biospace
16d
Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resilience
biopharma dive
16d
Women travel thousands of miles for a reproductive moonshot. Scientists say they’ve been misled
stat
16d
Drugmakers rush to pair up with Summit’s ivonescimab ahead of key verdict
biospace
16d
Plug-and-play gene therapy: FDA executes on vision that’s been in the works for years
biospace
17d
Can Saudi Arabia's burgeoning biotech hub withstand geopolitical pressures?
biospace
19d
Regeneron achieves ‘clean sweep’ in Q3 with myriad pipeline catalysts on deck
biospace
19d
STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more
stat
19d
Opinion: What a mother’s 1834 letter about measles tells us about MAHA
stat
20d
Merck looks ahead to ‘another year of investment’ as Keytruda cliff looms
biospace
20d
Chutes & Ladders—Lilly unifies global markets as 36-year vet Patrik Jonsson retires
fiercebiotech
20d
Flagship blends three biotech startups to form Etcelera
biopharma dive
21d
Recon: FDA approves Stada’s Lucentis biosimilar; Lilly says ‘triple-G’ candidate bests Ozempic in diabetes
raps
21d
Biogen set up for growth even without M&A but CEO won’t rule it out
biospace
21d
FDA’s rare disease framework aims to ‘stand the test of time’
fiercebiotech
21d
Biogen notches 3rd straight quarter of growth thanks to newer products, Apellis
biospace
21d
Biogen CEO tells analysts he’s focused on early-stage R&D as ‘we were not very good with that’
fiercebiotech
22d
HAIFA SMOKED FISH Recalls Cold Smoked Sprats Due to Potential Health Risk
fda recalls
22d
From RAS rivalries to leaked cancer vaccine readouts, ESMO brought the data drama
fiercebiotech
23d
Corxel, an obesity drugmaker, to go public via SPAC deal
biopharma dive
23d
Aspen, Bambusa target $135M IPOs; AstraZeneca vs. Takeda in gastric cancer ADCs
endpoints
23d
Anthropic lays out drug R&D ambitions, risks in mammoth IPO filing
fiercebiotech
24d
Neurogene, Taysha near finish line in ‘two-horse race’ for first Rett syndrome gene therapy
biospace
25d
Opinion: Christina Applegate puts a face on one of the most consequential challenges in neurology
stat
26d
ESMO 2026: Marengo's bispecific antibody shrinks 8 tumor types in Phase 2
biospace
27d
STAT+: Will the Treasury restrict U.S. investment in the Chinese biotech sector?
stat
27d
Roche’s pipeline trim claims Poseida’s off-the-shelf CAR T asset
biospace
27d
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
stat
← prev
page 3 of 14
next →